Industry Research

  1. Outsourcing Motivations Should Guide One’s Outsourcing Approach
    5/31/2019

    Outsourcing motivations are important considerations to identifying the best outsourcing approach and should influence the type of relationships your organization develops with CMOs. Data comes from ISR’s CMO Quality Benchmarking suite of market research reports and ISR’s Development and Commercial Outsourcing Models market research report.

  2. Trends In Phase 4 CRO Selection Drivers
    5/31/2019

    As part of our yearly service provider quality benchmarking, Industry Standard Research asks late-phase decision makers to select their top five most important attributes when outsourcing with no preferred providers.

  3. Influence Of Size In CRO Selection
    5/1/2019

    ISR surveyed hundreds of clinical development outsourcers about what they consider important when selecting providers. To capture the increasing role that preferred provider agreements are playing in the selection process, respondents were asked about attribute importance in several scenarios.

  4. How Prevalent Are PPAs In Phase 2/3 Research?
    5/1/2019

    Almost half of survey respondents report their companies use formal preferred provider agreements (PPAs) for their Phase 2/3 outsourcing.

  5. Are Outsourcers Interested In Changing Their CRO Mix?
    4/1/2019

    ISR recently surveyed decision makers across all phases of clinical development to gain insight on sponsor/CRO dynamics. More than half of respondents agreed (to some level)that their organization would change its mix of CROs.

  6. A Look At 2018’s CDMO Expansions
    12/3/2018

    ISR looked at each month in the past year to identify the biggest expansion news announced by large CDMOs.

  7. Decision-making Responsibilities When Outsourcing Late-Phase Studies
    11/7/2018

    A look at which departments at sponsor organizations are involved in the decision-making process and how much decision-making responsibility each department has for outsourcing various late-phase study activities.

  8. The Interconnected World Of Blockbuster Oncology Drugs
    11/7/2018

    A hypertree showing the network of connections between 2017’s top-selling oncology products. Oncology drugs made up 13 of last year’s top 50 selling products.

  9. The Top 5 Selection Drivers For Phase IV Services
    10/4/2018

    Understanding which attributes industry peers feel are important can help in the process of CRO selection.

  10. Department Influence On CMO Selection
    9/3/2018

    When it comes to CMO selection, Executive Management and Manufacturing/Production hold the most influence over the decision, each accounting for ~20% of control.